Skip to main content
Signal8

Calithera Biosciences, Inc. (CALA)

Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.

Sector: Biotechnology

Industry: Biotechnology

Calithera Biosciences, Inc. logo

Calithera Biosciences, Inc.

OTC:CALAHealthcare
CLOSED
Mkt Cap$487
EV-
Float4.83M
O/S4.87M
VOL345 sh
$ Vol$0
RVOL0.31×
Inst Own-
SI0.1%
Net Cash/Sh-
EarningsNov 17 · Today
Dilution

No press releases found for CALA.